18 June 2013
13 April 1992
The Chilean pharmaceutical comp-any Silesia is continuing to expand at is base in Santiago. The company its currently working on...
13 April 1992
Hoffmann-La Roche has indicated that it expects to begin Phase III trials with its mono-amine oxidase type B-selective inhibitor lazabemide...
13 April 1992
A safer treatment for traveller's diarrhea may soon be available, which will be suitable for use by adults, children and...
6 April 1992
The costs of depression to the National Health Service in the UK are L 333 million per year, according to...
6 April 1992
The US concern Roberts Pharma-ceutical has reached a definitive agreement to acquire the National Clinical Research Centers in the USA...
6 April 1992
Edwin Nathan, president of Glaxo France and of the group's Belgian and Luxembourg companies, has announced his departure from the...
6 April 1992
Sorin Biomedica made net profits in 1991 of 12.3 billion lire ($9.9 billion), up from 11 billion lire in the...
6 April 1992
Speaking at the 12th International Symposium on Intensive Care and Emergency Medicine in Brussels, late last month, Andre Heyns, Roussel-...
6 April 1992
Researchers at the Walter Reed Army Institute of Research and at Interferon Sciences have commenced Phase I trials with the...
6 April 1992
Appointed as senior associates for the pharmaceutical industry at PA Consulting Group are Keith Mansford, former chairman of R&D...